Correlation of SARS-CoV-۲ Infection with Hepatitis and Liver Disorders

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 58

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JMMI-9-3_003

تاریخ نمایه سازی: 29 بهمن 1402

Abstract:

The coronavirus infectious disease-۲۰۱۹ (COVID-۱۹) caused by severe acute respiratory syndrome coronavirus-۲ (SARS-CoV-۲) has become a severe global health challenge. The primary target for this virus is the lung. However, SARS-CoV-۲ can also attack other organs, including the kidney and liver.  Some COVID-۱۹ case reports demonstrated elevated liver enzymes such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin. Indeed, higher levels of liver enzymes occur in severe cases compared with mild to moderate cases. The relationship between liver injury and COVID-۱۹ might be due to various possible reasons such as reactivation of pre-existing liver disease, viral replication in hepatic cells causing direct cytotoxicity, liver ischemia and hypoxia, cytokine storm, and drug-induced liver injury (DILI). Thus, hepatitis prevention and care services are necessary during the COVID-۱۹ pandemic. For instance, drugs that might reactivate hepatitis B should not be prescribed for treating COVID-۱۹. Generally, the long-term effects of SARS-CoV-۲ on human health and various organs are not well understood. This review briefly discusses the relationship between SARS-CoV-۲ and liver injury (hepatitis), coinfection of hepatitis and COVID-۱۹, and SARS-CoV-۲ infection in autoimmune hepatitis.

Authors

Kimia Kardani

Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran

Azam Bolhassani

Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran

Mona Kardani

Iranian Comprehensive Hemophilia Care Center, Tehran, Iran

Elnaz Agi

Iranian Comprehensive Hemophilia Care Center, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Kardani K, Bohassani A. Vaccine development against SARS-CoV-۲: from virology ...
  • Zhou F, Yu T, Du R, Fan G, Liu Y, ...
  • Shenoy N, Luchtel R, Gulani P. Considerations for target oxygen ...
  • Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-۱۹ ...
  • Zhang C, Shi L, Wang FS. Liver injury in COVID-۱۹: ...
  • Huang C, Wang Y, Li X, Ren L, Zhao J, ...
  • Wang D, Hu B, Hu C, Zhu F, Liu X, ...
  • Chen N, Zhou M, Dong X, Qu J, Gong F, ...
  • Guan WJ, Ni ZY, Hu Y, Liang W, Ou C, ...
  • Liu W, Tao ZW, Lei W, Yuan ML, Liu K, ...
  • Mendlowitz AB, Naimark D, Wong WL, Capraru C, Feld JJ, ...
  • Hutin YJF, Bulterys M, Hirnschall GO. How far are we ...
  • Horton R. Offline: a dangerous virus, but not the one ...
  • Karimi-Sari H, Tajik M, Bayatpoor ME, Alavian SM. Increasing the ...
  • Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, ...
  • Hu LL, Wang WJ, Zhu QJ, Yang L. Novel coronavirus ...
  • Mao R, Liang J, Shen J, Ghosh S, Zhu LR, ...
  • Alqahtani SA, Schattenberg JM. Liver injury in COVID-۱۹: The current ...
  • Li L, Li S, Xu M, Yu P, Zheng S, ...
  • Wang D, Hu B, Hu C, Zhu F, Liu X, ...
  • Preziosi ME, Monga SP. Update on the mechanisms of liver ...
  • Ridruejo E, Soz A. The liver in times of COVID-۱۹: ...
  • Sachdeva S, Khandait H, Kopel J, Aloysius MM, Desai R, ...
  • Chauhan N, Jaggi M, Chauhan SC, Yallapu MM. COVID-۱۹: Fighting ...
  • Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, ...
  • Yang P, Wang X. COVID-۱۹: A new challenge for human ...
  • Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. ۲۰۱۱; ...
  • de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. ...
  • Parvez MK. COVID-۱۹ and coronaviral hepatitis: evidence of collateral damage. ...
  • Wu A, Peng Y, Huang B, Ding X, Wang X, ...
  • Chan JF, Kok KH, Zhu Z, Chu H, To KKW, ...
  • Masters PS. The molecular biology of coronaviruses. Adv Virus Res. ...
  • Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis ...
  • Fung TS, Liu DX. Human coronavirus: Host-pathogen interaction. Annu Rev ...
  • Zhou P, Yang XL, Wang XG, Hu B, Zhang L, ...
  • Wu F, Zhao S, Yu B, Chen YM, Wang W, ...
  • https://doi.org/۱۰.۱۱۰۱/۲۰۲۰.۰۱.۲۴.۹۱۹۱۸۳Wrapp D, Wang N, Corbett K, Goldsmith JA, Hsieh CL, ...
  • Wang H, Yang P, Liu K, Guo F, Zhang Y, ...
  • Wu F, Zhao S, Yu B, Chen YM, Wang W, ...
  • Glowacka I, Bertram S, Müller MA, Allen PD, Soilleux EJ, ...
  • Shang J, Wan Y, Luo C, Ye G, Geng Q, ...
  • Knell AJ. Liver function and failure: the evolution of liver ...
  • Tarasenko TN, McGuire PJ. The liver is a metabolic and ...
  • Gordillo M, Evans T, Gouon-Evans V. Orchestrating liver development. Development. ...
  • Robinson MW, Harmon C, O'Farrelly C. Liver immunology and its ...
  • Koo SH. Nonalcoholic fatty liver disease: Molecular mechanisms for the ...
  • World Health Organization. Brazil Health Profile ۲۰۱۶; http://www.who.int/en/news-room/fact-sheets/detail/the-top-۱۰-causes-of-death ...
  • Caetano KA, Bergamaschi FP, Carneiro MA, Pinheiro RS, Araújo LA, ...
  • Bashir S, Assadullah Z, Kumar A, Barik M. Correlation of ...
  • Wallace MC, Friedman SL. Hepatic fibrosis and the microenvironment: fertile ...
  • Bataller R, Gao B. Liver fibrosis in alcoholic liver disease. ...
  • Zhao J, Zhang Z, Luan Y, Zou Z, Sun Y, ...
  • Wilbur K. Non-viral hepatitis. J Pharm Pract. ۲۰۰۹; ۲۲ (۴): ...
  • Mantovani A, Beatrice G, Dalbeni A. Coronavirus disease ۲۰۱۹ (COVID-۱۹) ...
  • Raza S, Rajak S, Anjum B, Sinha RA. Molecular links ...
  • Wallace MC, Friedman SL, Mann DA. Emerging and disease-specific mechanisms ...
  • World Health Organization. Global hepatitis report ۲۰۱۷ ...
  • Kardani K, Basimi P, Fekri M, Bolhassani A. Antiviral therapy ...
  • Ogholikhan S, Schwarz KB. Hepatitis vaccines. Vaccines (Basel). ۲۰۱۶; ۴ ...
  • Basirnejad M, Bolhassani A, Sadat SM. The distinct role of ...
  • Moradpour D, Penin F, Rice CM. Replication of hepatitis C ...
  • Santantonio T, Wiegand J, Gerlach JT. Acute hepatitis C: Current ...
  • Bartosch B, Vitelli A, Granier C, Goujon C. Cell entry ...
  • Abdelwahab K, Ahmed Said ZN. Status of hepatitis C virus ...
  • Kinchen VJ, Zahid MN, Flyak AI, Soliman MG, Learn GH. ...
  • Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following ...
  • Poustchi H, Esmaili S, Mohamadkhani A, Nikmahzar A, Pourshams A, ...
  • Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, ...
  • Liu CJ, Kao JH. Global perspective on the natural history ...
  • Valaydon ZS, Locarnini SA. The virological aspects of hepatitis B. ...
  • Dane DS, Cameron CH, Briggs M. Virus-like particles in serum ...
  • Tuttleman JS, Pourcel C, Summers J. Formation of the pool ...
  • Tu T, Budzinska MA, Shackel NA, Urban S. HBV DNA ...
  • Tsai KN, Kuo CF, Ou JJ. Mechanisms of hepatitis B ...
  • Martin A, Lemon SM. Hepatitis A virus: From discovery to ...
  • Farci P. Delta hepatitis: An update. J Hepatol. ۲۰۰۳; ۳۹: ...
  • Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, ...
  • Flores R, Gas ME, Molina-Serrano D, Nohales MA. Viroid replication: ...
  • Chao M, Hsieh SY, Taylor J. Role of two forms ...
  • Chang FL, Chen PJ, Tu SJ, Wang CJ, Chen DS. ...
  • Smith DB, Izopet J, Nicot F, Simmonds P, Jameel S, ...
  • Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, ...
  • Kamar N, Izopet J, Pavio N, Aggarwal R, Labrique A, ...
  • Xu Z, Shi L, Wang Y, Zhang J, Huang L, ...
  • Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, ...
  • Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, ...
  • Sun J, Aghemo A, Forner A, Valenti L. COVID-۱۹ and ...
  • Hammond A, Ramersdorfer C, Palitzsch KD, Scholmerich J, Lock G. ...
  • Shiota G, Harada K, Oyama K, Udagawa A, Nomi T, ...
  • Chai X, Hu L, Zhang Y, Han W, Lu Z, ...
  • https://doi.org/۱۰.۱۱۰۱/۲۰۲۰.۰۲.۰۳.۹۳۱۷۶۶Li Y, Hu Y, Yu J, Ma T. Retrospective analysis ...
  • Horvatits T, Drolz A, Trauner M, Fuhrmann V. Liver injury ...
  • Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, ...
  • Wan S, Yi Q, Fan S, Lv J, Zhang X, ...
  • Hanafy AS, Abd-Elsalam S. Challenges in COVID-۱۹ drug treatment in ...
  • Sun X, Wang T, Cai D, Hu Z, Chen J, ...
  • Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, ...
  • Liu J, Li S, Liu J, Liang B, Wang X, ...
  • Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, ...
  • Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, ...
  • Lee D. Tylenol liver damage: signs, symptoms, dosage, treatment. MedicineNet ...
  • U.S. Food & Drug Administration. Remdesivir EUA letter of authorization ...
  • U.S. Food and Drug Administration. FDA approves fi rst treatment ...
  • Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, ...
  • Szabo L. Chasing the elusive dream of a COVID cure. ...
  • Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, ...
  • Gadour E, Hassan Z, Shrwani K. COVID-۱۹ Induced Hepatitis (CIH), ...
  • Fang D, Ma J, Guan J, Wang M, Song Y, ...
  • Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, ...
  • Lu H, Ai J, Shen Y, Li Y, Li T, ...
  • Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, ...
  • Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and ...
  • Chen X, Jiang Q, Ma Z, Ling J, Hu W, ...
  • Liu Y, Yang Y, Zhang C, Huang F, Wang F, ...
  • Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, ...
  • Chen LF, Mo YQ, Jing J, Ma JD. Short-course tocilizumab ...
  • Zha L, Li S, Pan L, Tefsen B, French N, ...
  • Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, ...
  • Liu R, Zhao L, Cheng X, Han H, Li C, ...
  • Mirzaie H, Vahidi M, Shokoohi M, Darvishian M, Sharifi H, ...
  • https://doi.org/۱۰.۱۱۰۱/۲۰۲۰.۱۰.۲۲.۲۰۲۱۶۳۱۷Tian D, Ye Q. Hepatic complications of COVID-۱۹ and its ...
  • Chen YW, Bennu Yiu CP, Wong KY. Prediction of the ...
  • Reddy KR, Beavers KL, Hammond SP. American Gastroenterological Association Institute ...
  • Gao LH, Nie QH, Zhao XT. Drug-drug interactions of newly ...
  • Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-۱۹. Life Sci. ...
  • https://doi.org/۱۰.۱۰۱۶/j.lfs.۲۰۲۰.۱۱۷۴۷۷Marjot T, Webb GJ, Barritt AS, Moon AM, Stamataki Z, ...
  • Gerussi A, Rigamonti C, Elia C, Cazzagon N, Floreani A, ...
  • Thng ZX, Smet MD, Lee CS, Gupta V, Smith, JR, ...
  • Marjot T, Buescher G, Sebode M, Barnes E, Barritt AS, ...
  • نمایش کامل مراجع